Case Study

Pfizer Uses Single-Use Collaboration To Achieve Speed To Market Goals

Source: GE Healthcare Life Sciences
Pfizer Uses Single-Use Collaboration To Achieve Speed To Market Goals

By John Coyne, Senior Manager, Pfizer Pilot Facility

As Pfizer began its pursuit of delivering two biosimilar monoclonal antibodies (mAbs) in China, it sought a partner that could mitigate the risks of expanding into this region while also significantly reducing the development timeline. By leveraging the expertise of an experienced partner and the benefits of single-use technology (SUT), Pfizer was able to quickly establish a global footprint while also gaining a competitive advantage in an emerging market.